Biotechnology

Published: Jan. 22, 2024 at 8:43 a.m. ET Shares of Gilead Sciences Inc. GILD tumbled 10.9% beating in premarket trading Monday, to pullback from an 11-month high, after the biotechnology company disappointing trial results…

New York, Jan. 17, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Cell Therapy Market size is forecasted to exceed USD 26.8 Billion by 2033, with a promising CAGR of 16.9% from 2024 to 2033. Cell therapy involves…

Medical personnel use a mammogram to examine a woman's breast for breast cancer.Hannibal Hanschke | dpa | Picture Alliance | Getty ImagesDuring the four-day event, the biotech and pharmaceutical industry signaled its enthusiasm for…

Walgreens' dividend yield is now 3.9%, based on Wednesday's closing price. That's down significantly from its prior yield of more than 7%, which made the company the highest-paying dividend stock in the Dow Jones Industrial Average. It…

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019.Mark Ralston | AFP | Getty ImagesJohnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall…

A federal jury in Miami convicted a Florida nurse practitioner of heath-care conspiracy and other charges for playing a key role in a scheme that swindled hundreds of millions of dollars from Medicare.Elizabeth Hernandez, 45,…

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023.George Frey | ReutersEli Lilly on Tuesday sued 10 medical…

CVS Health on Wednesday reported second-quarter earnings and revenue that beat expectations.CVS has implemented a cost-cutting program as it pushes deeper into healthcare services in the wake of two costly acquisitions.Part of that…

Merck reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. But the pharmaceutical giant posted a quarterly loss due to its acquisition of the biotech…

Rafael Henrique | Lightrocket | Getty ImagesEuropean Union regulators on Wednesday fined Illumina a record 432 million euros ($476 million) for closing its acquisition of cancer test developer Grail without first securing regulatory…